Katyal S L, Singh G
Exp Lung Res. 1984;6(3-4):175-89. doi: 10.3109/01902148409109246.
Glycoproteins of molecular weights (MW) of 38,000, 32,000, and 26,000 are found in surfactant isolated from rat lungs. These proteins were further examined for their specificity to pulmonary surfactant, structural and metabolic interrelationships, and relation to the ontogenesis of pulmonary surfactant. With ultracentrifugations in salt and sucrose density gradients, a preparation of pulmonary surfactant was isolated from rat lung lavage fluid, which was rich in surfactant lipids (phosphatidylcholine and phosphatidylglycerol), and contained exclusively the 38,000-, 32,000-, 26,000-, and 10,000- to 12,000-dalton proteins. The 38,000-, 32,000-, and 26,000-dalton proteins are not serum proteins. Using an antiserum specific for the combined 38,000-, 32,000-, and 26,000-dalton proteins and the immunoperoxidase technique, the source of one or more of these three proteins was found to be alveolar epithelial type II cells, the cells involved in the synthesis and secretion of pulmonary surfactant. These proteins, when dissociated from lipids, show considerable self-association and form homopolymers. On isoelectric focusing, these proteins show considerable charge heterogeneity, which, in large part, is due to terminally linked sialic acid residues. Partial proteolysis of these proteins and subsequent analyses of the released polypeptides suggest the existence of large segments of homology between the 38,000-, and 32,000-dalton proteins. The relationship of the 38,000-, and 32,000-dalton proteins with the 26,000-, and 10,000- to 12,000-dalton proteins is not clear as yet. The results of protein analyses of purified tubular myelin and of lamellar bodies suggest that the 26,000-dalton protein may be derived extracellularly, possibly from other surfactant proteins by the action of enzymes present in the alveolar lining layer. We observed no reactivity of the antibody raised against the 38,000-, 32,000-, and 26,000-dalton proteins with the 10,000- to 12,000-dalton protein. The 38,000-, 32,000-, and 26,000-dalton proteins appear during fetal lung maturation at the same gestational time as the surfactant is known to appear, and their combined content increases thereafter in fetal lungs and in amniotic fluid. It appears that the less glycosylated (32,000-dalton protein) of the 38,000- and 32,000-dalton proteins appears first during fetal lung development.
在从大鼠肺中分离出的表面活性剂中发现了分子量分别为38,000、32,000和26,000的糖蛋白。对这些蛋白质的肺表面活性物质特异性、结构和代谢的相互关系以及与肺表面活性物质个体发生的关系进行了进一步研究。通过在盐和蔗糖密度梯度中进行超速离心,从大鼠肺灌洗液中分离出一种肺表面活性物质制剂,该制剂富含表面活性物质脂质(磷脂酰胆碱和磷脂酰甘油),并且仅含有38,000、32,000、26,000以及10,000至12,000道尔顿的蛋白质。分子量为38,000、32,000和26,000的蛋白质不是血清蛋白。使用针对38,000、32,000和26,000道尔顿组合蛋白的抗血清以及免疫过氧化物酶技术,发现这三种蛋白中一种或多种的来源是肺泡II型上皮细胞,即参与肺表面活性物质合成和分泌的细胞。这些蛋白质从脂质中解离后,表现出相当程度的自我缔合并形成同聚物。在等电聚焦时,这些蛋白质表现出相当大的电荷异质性,这在很大程度上是由于末端连接的唾液酸残基所致。对这些蛋白质进行部分蛋白酶解并随后分析释放的多肽表明,38,000道尔顿和32,000道尔顿的蛋白质之间存在大片段的同源性。38,000道尔顿和32,000道尔顿的蛋白质与26,000道尔顿以及10,000至12,000道尔顿的蛋白质之间的关系目前尚不清楚。对纯化的管状髓鞘和板层小体进行蛋白质分析的结果表明,26,000道尔顿的蛋白质可能来源于细胞外,可能是通过肺泡内衬层中存在的酶对其他表面活性物质蛋白的作用而产生的。我们观察到,针对38,000、32,000和26,000道尔顿蛋白质产生的抗体与10,000至12,000道尔顿的蛋白质没有反应。38,000、32,000和26,000道尔顿的蛋白质在胎儿肺成熟期间与已知出现的表面活性物质在同一妊娠时间出现,并且它们的总含量在胎儿肺和羊水中随后增加。似乎在胎儿肺发育过程中,38,000和32,000道尔顿蛋白质中糖基化程度较低的(32,000道尔顿蛋白质)首先出现。